Galvokimig
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
UCB Biopharma SRL
Overview
Galvokimig is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Galvokimig clinical trials
Explore related
Medical disclaimer. This page summarizes research about Galvokimig for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.